Table 1.

Demographic and pre-procedural information

Characteristic	N	Percent
Total cases	472
Gender
Male	236	50
Female	236	50
Age
Mean±SD	70±16
Anticoagulation status
Warfarin	59	12.5
Mean INR±SD (n=55)	1.6±0.5
Rivaroxaban	1	0.2
No prior anticoagulation	412	87.3
Patients with INR>1.7	28	5.9
Dual Antiplatelet therapy	10	2.1
Thrombolytic therapy
IA tPA	103	21.8
IV tPA	123	26.1
IV and IA tPA	34	7.2
No tPA	212	44.9

IA, intra-arterial; tPA, tissue Plasminogen Activator.